Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Merck Receives FDA Acceptance For Filing Cladribine Tablets
Additionally, the NDA has also been granted a priority review designation by the FDA, which means the review period for the NDA is reduced, which allows for the
Additionally, the NDA has also been granted a priority review designation by the FDA, which means the review period for the NDA is reduced, which allows for the
The NCCN Oncology Research Program (ORP) facilitates all phases of clinical research by identifying clinical investigators and initiating trials at NCCN Member Institutions. GSK said that the ORP
The new tBili assay is performed on IL’s GEM Premier 4000 critical care analyzer. It allows clinicians to receive lab-quality test results in 90 seconds from whole blood
Luminex said that the instrument was designed to meet the needs of laboratories, academic researchers and scientists, who to date have not been able to take advantage of
Tris Pharma claimed that this is the first-ever generic ANDA approved by the FDA for an immediate release methylphenidate hydrochloride oral solution. As part of the approval, Tris
The Chinese Letters Patent No 1758920 covers pharmaceutical compositions that comprise the greater and superior dosage size of chondroitin sulfate, and the use of those compositions for the
Hospira has posted 227.5% increase in net income to $83.5m for the second quarter 2010, or $0.49 per diluted share, compared to $25.5m, or $0.16 per diluted share,
Methylphenidate is used to treat attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD), and narcolepsy. Tris Pharma claimed that this is the first-ever generic ANDA approved by
Trophos said that the study demonstrates the potential for TRO40303 to protect heart tissue from ischemia-reperfusion injury induced when treating myocardial infarction. Trophos claimed that TRO40303 acts by
Reportedly, since 2007, Mediomics has received over one million dollars of STTR funding to develop its quick and sensitive homogenous PINCER protein assay. Mediomics is currently focused on